Notice of Proposed Sale · 144
KORU Medical Systems, Inc.
KRMDNASDAQEQUITYCurrent
Notice of Proposed Sale
Structured filing — 144
primary_doc.xml
Notice of proposed sale. The proposed amounts below do not establish that a sale occurred.
Proposed-sale notice
- Issuer
- KORU Medical Systems, Inc.
- Issuer CIK
- 0000704440
- SEC file number
- 001-39086
- Phone
- 845-469-2042
- Person for whose account securities are to be sold
- KALBERMATTEN ADAM R
- Relationships to issuer
- Officer
- Street
- 100 CORPORATE DRIVE
- City
- MAHWAH
- State / country code
- NJ
- Postal code
- 07430
Securities proposed for sale
| Security | Proposed units | Aggregate market value | Units outstanding | Approximate sale date | Exchange | Broker / market maker |
|---|---|---|---|---|---|---|
| Common Stock | 25,483 | 108,629.00 | 45,933,000 | 08/03/2026 | Nasdaq | Stifel Nicolaus & Company Inc |
Broker / market maker — proposed row 1, entry 1
- Name
- Stifel Nicolaus & Company Inc
- Street
- 501 N Broadway
- City
- St. Louis
- State / country code
- MO
- Postal code
- 63102
Acquisition of securities to be sold
| Security | Acquired | Nature of acquisition | Acquired from | Amount acquired | Gift transaction | Payment date | Nature of payment |
|---|---|---|---|---|---|---|---|
| Common Stock | 07/28/2025 | Restricted Stock Award | Issuer | 75,000 | N | 07/28/2026 | Equity Compensation |
Prior-sale reporting
- Nothing to report for the preceding three months
- Y
Remarks
Shares sold to cover taxes due to a Restricted Stock vesting event
Notice signature
- Notice date
- 08/03/2026
- Signed
- /s/ James Weimer, as a duly authorized representative of STIFEL, as attorney-in-fact for Adam Kalbermatten
Company context
KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The Freedom Syringe Infusion System (the “Freedom System”) currently includes the Freedom60® and FreedomEDGE® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HigH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Pharma Service and Clinical Trials business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories. For more information, please visit www.korumedical.com.